Navelbine and haemoglobin decreased Patient Reports February 11, 2012

Navelbine Side Effects Report #4788616-4
Navelbine side effect was reported by a Health Professional from GERMANY on Sept 30, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain , blood bilirubin increased, dyspnoea, fatigue, haemoglobin decreased, jaundice , leukopenia, oedema peripheral. Navelbine dosage: unknown. During the same period patient was treated with GEMCITABINE, XIPAMIDE, KALINOR, INSULIN, MOVICOL. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5707964-4
Navelbine side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 60 years of age, weighting 101.4 lb, was diagnosed with metastases to bone and was treated with Navelbine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone disorder, gingival recession, haematocrit decreased, haemoglobin decreased, impaired healing, osteomyelitis, osteonecrosis . Navelbine dosage: 27 MG. During the same period patient was treated with LENDORMIN, FEMARA, AREDIA, ZOMETA. Patient recovered.

Navelbine Side Effects Report #5680240-4
Navelbine side effect was reported by a Physician from JAPAN on Mar 13, 2008. Female patient was diagnosed with metastases to bone and was treated with Navelbine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone disorder, gingival recession, haematocrit decreased, haemoglobin decreased, impaired healing, osteomyelitis, osteonecrosis . Navelbine dosage: 27 MG. During the same period patient was treated with LENDORMIN, FEMARA, AREDIA, ZOMETA. Patient recovered.

Navelbine Side Effects Report #4995871-4
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2006. Male patient, 71 years of age, was diagnosed with lung neoplasm malignant, rheumatoid arthritis  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, fatigue, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, melaena, pneumocystis jiroveci pneumonia, po2 decreased. Navelbine dosage: unknown. During the same period patient was treated with VOLTAREN, PREDONINE, RIMATIL, AMLODIN, BLOPRESS, GLUFAST. Patient died on 10/17/2005.


Navelbine Side Effects Report #4748838-5
Navelbine side effect was reported by a Health Professional from JAPAN on Sept 14, 2004. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: erythropenia, febrile neutropenia, haemoglobin decreased, pyrexia, white blood cell count decreased. Navelbine dosage: 28MG PER DAY. During the same period patient was treated with CISPLATIN, LOXOPROFEN, MUCOSTA, SPIROPENT, MUCOSOLVAN, ALGINATE. Patient recovered.

Navelbine Side Effects Report #5844445-1
Navelbine side effect was reported by a Health Professional from JAPAN on July 30, 2008. Male patient, 68 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, leukopenia, platelet count decreased, platelet disorder, red blood cell count decreased, upper respiratory tract inflammation. Navelbine dosage: 25 MG/M2 ONCE IV. During the same period patient was treated with FOIPAN, HYPEN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5679159-4
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Mar 07, 2008. Female patient, 68 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: arrhythmia , cerebral infarction, external ear inflammation, facial palsy, gastritis haemorrhagic, haemoglobin decreased, injection site phlebitis, leukopenia, mouth ulceration. Navelbine dosage: 25 MG/M2 QD IV. During the same period patient was treated with ENALAPRIL MALEATE, GLIMICRON, TAKEPRON, CORTRIL, CYANOCOBALAMIN, RYTHMODAN P, AMIODARONE. Patient was hospitalized and became disabled. Patient recovered.

Navelbine Side Effects Report #5702449-3
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Mar 25, 2008. Female patient, 68 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: arrhythmia , cerebral infarction, external ear inflammation, facial palsy, gastritis haemorrhagic, haemoglobin decreased, injection site inflammation, leukopenia, mouth ulceration. Navelbine dosage: 25 MG/M2 QD IV. During the same period patient was treated with ENALAPRIL MALEATE, GLIMICRON, LANSOPRAZOLE, COTRIL, CYANOCOBALAMIN, RYTHMODAN P, AMIODARONE. Patient was hospitalized and became disabled. Patient recovered.

Navelbine Side Effects Report #4742806-5
Navelbine side effect was reported by a Health Professional from GERMANY on July 07, 2005. Female patient, 53 years of age, was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal distension, back pain , chest discomfort, circulatory collapse, dyspnoea, haemoglobin decreased, leukopenia. Navelbine dosage: unknown. During the same period patient was treated with DEXAMETHASONE, KEVATRIL, CARVEDILOL, CAPTOPRIL, DIGIMERCK, FUROSEMIDE, SPIRONOLACTONE, MISTLETOE. Patient died on 06/29/2005.